PATENT CLAIM ANALYSIS

Application Number: 15760366
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["544", "121000"]

Abstract:
An object to be dissolved by the present invention is to provide a crystal superior in storage stability and in hygroscopy, in particular, while ensuring sufficient reproducibility. The present invention provides crystals of a monohydrate of 4-((1-methylpyrrol-2-yl)-carbonyl)-N-(4-(4-morpholin-1-yl-carbonylpiperidin-1-yl)-phenyl)-1-piperazinecarboxamide.

Claim (Index 10):
The crystal according to  claim 6 , wherein the crystal has at least 2 peaks of diffraction angle (2\u03b8\u00b10.2\u00b0) selected from 12.8\u00b0, 15.0\u00b0, 17.2\u00b0, 19.8\u00b0, 21.5\u00b0, 21.8\u00b0, 22.5\u00b0, 25.8\u00b0, and 27.5\u00b0 in a powder X-ray diffraction spectrum.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 90.0
- Lexical Diversity: 1.4
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15562455', '15328795', '15572398', '15570779', '15748283']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7989896155128148
- 35 USC 102 Novelty (BERT): 0.559973268906479
- Combined Prediction Score: 0.7750879808521811
- Mean Citation Score: 406.9662119999999
- Max Citation Score: 423.3612
- Similarity Product: 386.299138276434

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test